Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Some synthesized compounds were more effective than Finasteride in reducing prostate cancer cell growth and androgen levels.

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

New progesterone-based compounds can block male hormones.

The MPA-ISO cocrystal improved solubility and dissolution rate, while the others did not.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

Mimicking the steroid A-ring may help create effective enzyme inhibitors for prostate disease treatment.

A new combination of tadalafil and finasteride improves drug performance and stability.

The new compounds may be more effective and cheaper than current treatments for conditions like baldness.

Majoon Ushba and Marham Gulabi effectively treat dermatophytosis.

Combining tadalafil and finasteride improves their solubility and effectiveness.

Modified steroidal inhibitors showed promise in treating hormone-dependent cancers.

Changing the C-ring structure in certain compounds can make them better at blocking a specific human enzyme.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

The research created new azasteroids and pseudoazulenyl nitrones, which could be useful in medicine.

Indole-based compounds improved ovarian health in rats with PCOS, with L-Tryptophan and Tryptophol being most effective.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

Hexahydrobenzo[f]quinolines are effective at blocking the enzyme 5α-reductase.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

TrichoSolTM is safe for hair loss treatments with specific ingredient stability for up to 180 days.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

Bedaquiline, Telmisartan, Diosmin, Azelastine, and Adapalene may be effective treatments for onchocerciasis.

Adapalene, Diosmin, and Azelastine may effectively treat onchocerciasis.

Adapalene, Diosmin, and Azelastine may effectively treat onchocerciasis.

New anti-acne medications are being tested to offer alternatives to current treatments.

Minoxidil analogs can be improved for hair growth inhibition by modifying specific parts of their structure.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.